About Alan Crane
Form D filings for Seismic Therapeutic from 2023 to 2024 list Alan Crane as director.
Alan Crane reports to the SEC as a director, officer or major shareholder of 7 public companies, including Pandion Therapeutics (PAND), Vaccinex (VCNX) and Dare Bioscience (DARE).
Alan Crane first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Alan Crane in the role, so the role may have started earlier or lasted longer.
PI
Pandion Therapeutics, Inc.
Director and 10% owner
2020 – 2021 · Public company (PAND)
VI
Vaccinex, Inc.
Director
2019 · Public company (VCNX)
DI
Dare Bioscience, Inc.
Director and 10% owner
2014 – 2016 · Public company (DARE)
TI
T2 Biosystems, Inc.
Director
2014 · Public company (TTOO)
OI
Ocular Therapeutix, Inc.
Director
2014 · Public company (OCUL)
MI
Momenta Pharmaceuticals Inc.
C.e.o and director
2006 – 2010 · Public company (MNTA)
SI
Sirtris Pharmaceuticals, Inc.
Director
2007 · Public company (SIRT)
Key Colleagues at Startups
The people Alan Crane works with at each company, as listed on that company's latest Form D.
Seismic Therapeutic, Inc. · Form D/A, Sep 12, 2024
TS
Timothy Springer
Director
EF
Edward Freedman
Executive officer
AH
Andrew Hedin
Director
JE
Julie Eastland
Director
SC
Shelley Chu
Director
JV
Joanne Viney
Executive officer and director